The role of radiotherapy in non-small cell lung cancer

Chest

Volumn 116, Issue 6 SUPPL., 1999, Pages 504S-508S

  Sause, William T ^a  

^a LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; LOMUSTINE; METHOTREXATE; MITOMYCIN; VINBLASTINE; VINCRISTINE; VINDESINE;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME;

EID: 0033397851     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_3.504s     Document Type: Article

References (40)

1. Ginsberg RJ, Vokes EE, Raben A. Non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia, PA: Lippincott, 1997; 858-911
2. Morrison R, Deeley TJ, Cleland WT. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1963; 1:683-684
3. Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992; 24:3-9
4. Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27:517-523
5. Noordijk EM, v d Poest Clement E, Hermans J, et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 1988; 13:83-89
6. Smart J. Can lung cancer be cured by irradiation alone? JAMA 1966; 195:1034-1035
7. Talton BM, Constable WC, Kersh CR. Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1990; 19:15-21
8. Zhang HX, Yin WB, Zhang LJ, et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 1989; 14:89-94
9. Carroll M, Morgan SA, Yarnold JR, et al. Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol 1986; 22:1353-1356
10. Bleehan NM, Girling DJ, Fayers PM, et al. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions; report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer 1991; 63:265-270
11. Simpson JR, Francis ME, Perez-Tamayo R, et al. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985; 11:751-758
12. Teo P, Tai TH, Choy D, et al. A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1988; 14:867-871
13. Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205
14. Sause W, Scott G, Byhardt R, et al. Recursive partitioning analysis of 1,592 patients on four RTOG studies in non-small cell lung cancer [abstract 1123]. Proc Am Soc Clin Oncol 1993; 12:336
15. Wagner H Jr. Radiation therapy in the management of patients with unresectable stage IIIA and IIIB non-small cell lung cancer. Semin Oncol 1997; 24:423-428
16. Perez CA, Stanley K, Grundy G, et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer 1982; 50:1091-1099
17. Bauer M, Birch R, Pajak RT. Prognostic factors in cancer of the lung. In: Cox JD, ed. Syllabus: a categorical course in radiation therapy; lung cancer. Oak Brook, IL: Radiological Society of North America (RSNA) Publications, 1985; 116-117
18. Scott C, Sause WT, Byhardt R, et al. Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer. Lung Cancer 1997; 17(suppl 1):S59-S74
19. Withers MR, Thomas MD, Peters LJ. Differences in the fractionation response of acutely and late responding tissues. In: Kaercher KM, Kogelnik D, Reinartz G, eds. Progress in radio-oncology. New York, NY: Raven, 1982; 287
20. Seydel HG, Diener-West M, Urtasun R, et al. Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: preliminary report of a RTOG pilot study. Int J Radiat Oncol Biol Phys 1985; 11:1841-1847
21. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 70.2 Gy: possible survival benefit with ≥ 60.0 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma; report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990; 8:1543-1555
22. Macbeth FR, Bolger JJ, Hopwood P, et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status: Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 1996; 8:167-175
23. Saunders MI, Lyn BE, Dische S. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer. Lung Cancer 1993; 9:221-228
24. Saunders MJ, Barltrop MA, Rassa P, et al. The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1984; 10:503-508
25. Dillman RO, Herndon J, Seagren SL, el al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Tust 1996; 88:1210-1215
26. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemorherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83:417-423
27. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: a meta-analysis. Ann Intern Med 1996; 125:723-729
28. Komaki R, Scott C, Ettinger D, et al. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 1997; 398:149-155
29. Sause WT, Scott C, Taylor S, et al. Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer: Radiation Therapy Oncology Group 88-04. Am J Clin Oncol 1992; 15:163-167
30. Byhardt RW, Scott C, Ettinger DS, et al. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Cancer 1995; 75:2337-2344
31. Komaki R, Scott C, Lee JS, et al. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. Am J Clin Oncol 1997; 20:435-440
32. Ruekdeschel JC. Combined modality therapy of non-small cell lung cancer. Semin Oncol 1997; 24:429-439
33. Mattson K, Holsti LR, Holsti P, et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 4:477-482
34. Morton RF, Jett JR, Maher L, et al. Randomized trial of thoracic radiation therapy (TRT) with or without chemotherapy for treatment of locally unresectable non-small cell lung cancer (NSCLC) [abstract 772]. Proc Am Soc Clin Oncol 1988; 7:200
35. Belani CP. Multimodality management of regionally advanced non-small-cell lung cancer. Semin Oncol 1993; 20: 302-314
36. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6:663-641
37. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326:524-330
38. Jeremic B, Shibamoto Y, Acimovic L, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 1996; 14:1065-1070
39. Trovó MG, Minatel E, Franchin G, et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24:11-15
40. Takada Y, Furuse K, Fukuoka M, et al. A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V), and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC): preliminary analysis [abstract 294]. Lung Cancer 1997; 18(suppl 1):76-77